Enda Martin Gribbon

Title: Enda Martin Gribbon: Innovator in Pharmaceutical and Material Science

Introduction

Enda Martin Gribbon is a notable inventor based in Cambridge, GB. He has made significant contributions to the fields of pharmaceutical formulations and material science. With a total of 2 patents, Gribbon's work focuses on innovative methods that enhance the stability and efficacy of various substances.

Latest Patents

Gribbon's latest patents include a method for stably incorporating substances within dry, foamed glass matrices. This invention provides methods for producing foamed glass and the compositions obtained thereby. The compositions are suitable for stable storage of a wide variety of substances, particularly biological and pharmaceutical. Another significant patent is for a tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient. This formulation includes clavulanic acid or its salt, amoxycillin, and amorphous anhydrous trehalose, which is present in an amount of 5 to 50%. The formulation may also comprise desiccants, such as silica gel, or lubricants.

Career Highlights

Throughout his career, Gribbon has worked with several prominent companies, including Elan Drug Delivery Limited and Quadrant Holdings Cambridge Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug delivery and material science.

Collaborations

Gribbon has collaborated with notable professionals in his field, including Bruce J Roser and Glen Patrick Martyn. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Enda Martin Gribbon is a distinguished inventor whose work in pharmaceutical formulations and material science has led to significant advancements. His innovative patents reflect his commitment to improving the stability and efficacy of important substances.